• No results found

Årsrapport 2012 for sykdomsprogrammet. Blod- og seksueltoverførbare sykdommer

N/A
N/A
Protected

Academic year: 2022

Share "Årsrapport 2012 for sykdomsprogrammet. Blod- og seksueltoverførbare sykdommer"

Copied!
33
0
0

Laster.... (Se fulltekst nå)

Fulltekst

(1)

www.fhi.no

Utgitt av Nasjonalt folkehelseinstitutt Desember 2013

Postboks 4404 Nydalen NO-0403 Oslo

Telefon: 21 07 70 00

Rapporten kan lastes ned gratis fra Folkehelseinstituttets nettsider www.fhi.no

Blod- og seksuelt-

overførbare sykdommer

Årsrapport 2012

for sykdomsprogrammet

Hans Blystad Hilde Kløvstad Venelina Kostova Øivind Nilsen Synne Sandbu

Kathrine Stene-Johansen Martin Steinbakk

Per Kristian Svendsen Inger Sofie Samdal Vik

2013

(2)
(3)

(&'(

#

#

"

"

"

#!

%

"

(4)

***,) %$"*%"!")$)**+**

,) %$%()#**,($

,"$%($!) %$)%,(,!$

)#(:89;

()(''%(*2"%4%)!)+"*%,(&(($!) %$(:89:

$)"/)*

$"$%)*%, ""&,)*

,$")$

*($*$4%$)$

(*$*$!!

(()*$,$)$

$(%#"!

''%(*$!$")*)$)%#'

'%"!")$)**+***)$**)(2---33$%

''%(*$!$%))*"")(

) %$"*%"!")$)**+**

%)*%!)<<8</"$

48<8;)"%

'+"!) %$53$%

"%$2:98?@:88

"!)2:98?@98=

(()*$,$)$%(*&#(

$$ ()*$

988

%"%+(%.

A?@4@:4@8@:4>8;4A*(/!*,() %$

A?@4@:4@8@:4>8<4>

$")*(

(5)

"$ *& !!*$%$##"$&!"$%)" %#$"$ &"3"%%'&"($-$$

!%"!$$*!"($%&"($'!%"!$%" '&-$%("%!%&&'&&&2&&

" &&$(!%"!0"!"$,0%)%0!& )!%"!"#&&&5000062

!!$##"$&!" &&$'!%"!!# ""%"($(*!"!)%0

"$&"$'!$%-%$"(%!%&$'%"!""($(*!((%!!!"$

!!$*$%$##"$&!%" %'&(%)" %#$"$ &2*$'##!"$!!

*$%$##"$&!$#$ +$&% )!&$"%#$%"!#$ +$3"

%#%%&%&!%&!2

)" %#$"$ &&$&!!!"$'%)" %$'##$((%"!"$

% &&($!(*$%%&9788389"$*$(% $&"%$!"$ %"!%)&#*

&($%((!!2)" %#$"$ &"$""%%'&"($-$$!%

" &&$$%&&($'%#&&&$0(3!%"!0"!"$,0%)%"!&

)!%"!2

($%&!$%$&#*&!!% &$1

• !%%)%& "$% &&%" %)" $5 6

• '!$%-%$'&-$&($$!%"$&"$&"$#&&&($'%

• *!% !$"($#"%&(#$-($!!!($""$!&% $"""%

"$&"$$

• %&&%&$'&($!((%!$$"%!%&&'&&&0!'$&(%!$%"

%("&$)!&&$4*$%#&"$%$&!42

• !%"!&(%!%"!%$%&$56

&" ($-0%% $!$%&!0-$'$'&$" $!&%$"$

&$&$##"$&!2

(6)

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%+

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%,

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%-

" %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%/

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%)*

#%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%),

# %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%).

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%)1

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%*(

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%*.

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%*0

! !%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%*1

(7)

" #$&##%$ &"-""#( &# 0 ", #(#&"

!*6;;52$$& "0##%$$&6;;52$$"#$$$(

-&###( 1$$#(# &#(#$$$# "

#'3#41#$##$$####( &$#'

# 0$"$#$$"#*#$$#$-&" "0#+"#$-""

("# "0" $&"1#" #*"$&$"&

&# 0 ", %$$!$$$$$" ##%# "#$$$&

%$#"#0#!#$ !!1&( #$#"$&$"

##%$$&6;;52$$#(#$$-$ #*#$ ""#$$

##(#-"0($" &""# "#$$$$"

# " #$#"$$$" #$$ "1

$$"65*"*"#$$ #$#"$$"&$(#

$#(## $##$*""&+"$#$#"& " #$1 #"&"$$ #$#"$$"#(#-"#$ "#$

$(#$$1" " #""#"$-(#$##"$

1("$#" "$ $"%!"+"#$#$!%#"$

!"75681$"* #((655'7:"0" #((

755'6:"0")$" (6# # #1)$" (-"%*# "

$""##$#"&1

" #$&!$$$ %$$!$$$"##$*"&+"$&$$"$$(

%$"%&###( !*#%$$&6;;52$$1$ #$#"$$"&

" #!$$$"$""$&""" 2 -(# "*"

# *" " "1!$$$2#$%# "#&" ## " # "#-$& ""#$"$$$#$$$ $""!**

#"#"%1&"$*"#$695527555$"&!$$$ "1 "$# # $"&(#$$!$$$ $"

& "#$$"# "*"#1

& "&" & ##$$%$$$"# $""# "$ "% "

!$$$2020202 2&"%# #%!!" $"$&$#$" "

&"&* "$"#"&&"%#"$ #$#%$"&!#$"1 (#"#%$$""!"+" "$ "!** &" !#$""$#"

&"$#&%#" #2" (+" #(#"1 7567$%$-"$

%"$&::55(#" "& !$$$&"%#!*!#$!"-&"0&##&"997 (#"%$-"$ "#&"$#""$#&&2"!$$$

# # &"1&!#$!"-&%$-" "$$31955542

!" $& "&&!"$&##(#"&"%#&$$"1

$$(##$"&$$# $" " "&"$#$" $2%& $" "#

$&$$##"&" # #$1#$"&$$# $" "

3"$#$"4##%$$ "!"*"0"$$*"$#$ " &"-""

#1$#$"#$$!* "$!" #$" %$ """

(8)

! '"

$# + +! " "

'#* "! # +1/01 ! # "*

* 2/// ,!" +

1/01 ! ! " 434/ ,"23 ," $!""" #

-$ .+ ! "% "

$* ! " ,"!

$+ " $!

"+ " 2/6"' 1//5,1/01$ & ,"' " ' "$+

(9)

"0875"& $ $ ,

$-.+1/01 131$"

-3)7 0/////.)055-589.65"+

157 1/00)$%"

#" ' + ! " " " " , 1/01! 1/00+ "" !

% " "%- 0.+ 20+01+1/01 4027" "

)235/0567"+

," " # $ % & ' ( ! + #! $ !" $" " &# % #% ## " !%'" #

&!$ #% % #$ ' %% ' && &# '% %$ %!% !%

"%! ! # % ! $(% $

"$ #& '

' # # $ ' " " " % &$ #

# " ' & $ ' " $

!$$$ !"' !$ ! ( !&% !#' !(( !'# !$' !%' !#! $ "' *) !

#-. %" 65" 1/01 86 1/00+ 1/01 ) '$

" "%" !%1/00+

1/01+1/01 21"65 +"00

! )'"! !

!+"17 ! 1/0102 !)) )+ " ! ! +

" ""!"& ' %+"

65 1/01 14"!)""08 " '" - 2.+"

14"!0/)% !) + "

1/01 '

1//2)" $ %' )

! "& " " $

(10)

$"!!-42346:085<1#% ! !!

!!!#!!,3:# !!32!# ! !!!!"!-

5906:<1#% ! !4234#! !!!! !,48

! !!# %" #/,35! !!& "!

#)! - !# !# ! !!

!#)%5;&03;.8:1!!4234!59&!!

4233-#!!4234#32 47&%& ! "!!-

! !!!#! "! !! &# # !# #

"! - !& ! !!##! ! !! , !#" "!

" !!!)!! !!-&!#

#!! "#!! "! !!!",

#- # !! !!! # !!!) !!

-

423468 05535#1 ! !!!! " !!

# !!-&!!) "!4233- !!! !&!!!6:!&"-

!# !&#'!!!! #" !!!

!!)!!!#&# !! "

!&-4234#55094<1#68!")!, 35#"-

!& !! !## ! !!

& #! "! !!!-#35#&# !4234; !!!

9# !!!#! !!-!!#! &# !

! " !!#) " ! ",(

##&# !4234 !!!# "!-

!! "! !! ! !!!"!! #

"! !!&!!4234!!&-#55!

&# !42343;07:<1 !!!"!!- !% !!!

!! !"!!!4234, #! !!

37!4233-3:#55! !!!#!

"!!,##!!! $ !!"!0!"!!( 1-

4234! ! !;8%#!07:#5:1!

!! % )#-!!#!

!4233!!!32;!"-!!

"089<42341 !, ' !.- ! !! #0942331 !

# !

(11)

""7567'$!"66&!"! "$" "! !"1

! # ."$0""$" $ ! !"""

* " 0$!! !"1# 0$

" "!""" "! # !"""!) 0"!' 7567"!&$ "$!"".$ *" " !"

"2#"!"" # "$0 $!!

! !"" # "!"" #$ ".!*$ " #

$ 0

$!"#! ! ' "$""!"! "$"

"! "!"" '*.""&$" " ! ! ""

!!&!* $ !!""*&"3640"" "

*&"""$" "! !%7566"

!"! "$!"$ #$75975670" *

"'! &!"""!0 ' $( """"" ' *&$" '""' """ 0""

$( "# !$ "" "' *&"!""$""#$!""0

"'$!"" $ )"! "!""'*7567"" $

!&! !'"*&"$'.!"& ' !!%"!0

!#"$! !"$!"0

*$!!"!! #""'!" "" #"' 75550!"

" ""! "# !!"#34364"! " "! "1

! #!&"""!%0!'"!!$" $!"$ "$#!&"""

!%"&0"$ !"#"!"859$ !"

!" $!""#!!!!""!% " .!"" "!

$!""#! $$ ""!""! !!#"$ * !

"!!"' "0

"!

/.!!""#"""

0 50 100 150 200 250 300 350

1984 1987 1990 1993 1996 1999 2002 2005 2008 2011 Antall meldte tilfeller

(12)

&#$%# $$" ##% #$$ "5345#"%$$*&+""$&#$

%"$"5344/ "$#$$!*&##&#$$" ##%% "/

$#$"$$" ##% """$&+"$#&,&

(#$$. &""$$$& "$#$$/* " &""%$ ##,"

$&#$$$" ##% "$#$$&$"%## !!$ " $

#$$"# & "%&$#',"#*""$ #* ""%!!

$($".#(#," "$",(# "*" "&

"&$#!*$"$&$#$$,($&*##&"$$# "

$$ "##$*"/"$$"%!! "# $""

".#+""#$0"/ ##$$%$$$$"$ 473304933&""

*&"& " "%!!"!"#$""&"$*" &!"$&

#$#"$&$"

04"##$# &"&*%$,"#&# %&"#$$##(%#.&*. $$"

!*&#&!"+""##$#.&#"##$#%$# ","#$!",&"!#$# "

( #$#"$/"5344"04"##$#$##$$ (#"$"&

1##$# &"&&&"%# "2& ##$$%$$$#"&*/

"%$"$#$ &""##$#%$# " "*#$"#"04"##$#0 &"&*.#*$ 1%"&"%##$ %$$ #2. "#

&"##$#$!*$&"#&"#"/ ",&&#&#$(

*" "($$##!"##/5345.% !*&#$ #:;&

(#"$#&#.%7;&!",&"##$#%$# "&#

$(/#$$,(""##$# $&")&"!/

&"&*"&#$$"##$## #( #$#"$04$"#

#$*"!*$&". $ " #$"&$, ,",#&" "*

% !!&$%$,$"/$*&+"#(#$"$""$

!!%"$&83;&( #$#"$.#$5345&"93;/

" #&# &"#$$##(%#"# $""# "$ "% "

&/ ##$$%$$$%$,""& #$ "# $" & &"

"*%"$"&"$&# %$"$&#" #"

(+" #(#"1$52/$%$,"# #* $#$&!#$"#

&"&*.#$ "*%$("$#$" $0%& $" "$&$$#0

#"&& #$ "/5345$%$,"$796&0(#"/(#"

"#&"$#""$#&&# %$,"$ #6: &"/

Serologiske og genteknologiske analyser HIV-1 Antigen, ELISA

Anti-HIV-1/HIV-2 (IgG), ELISA Anti-HIV-2( IgG), Western blot Anti-HIV-1 (IgG), Western blot Anti-HIV /HIV-Antigen, ELISA Anti-HIV-1/Anti-HIV-2, Pepti-Lav

(13)

Serologiske og genteknologiske analyser HIV-1 DNA, PCR

HIV-1 RNA, RT-PCR

&)%*()*'*()*

# *()*

-)-.,.$ ! #

$ $ & +'#

År Anti-HIV HIV Ag

2005 567

2006 713

2007 698 91

2008 812 427

2009 793 793

2010 921 751

2011 940 773

2012 717 848

"!

(14)

! !##$ 8@@9'+#% ! )% $"%% $$)$%%!#$%%2

$!$)!#5 61 9789% !$%$#%;;:5?0?%#"#8777776

! !#,%#!#!%:>7%#97881%%# !#% '%

! !#,%# % $!#$( 5$69788# %%%#

#&"" -%97891 %%#!$$&%$%% !' ## %

%%#9789% #%!#!%$ #*#5961 % $!

#$( $$%*# $)$$%!##-%#&'! !#, !$2

% 1';;:% '#%:@9 !<8' #1' '#9:@$%%%

!!$$&%08;@'#$%%%%#!$$&%!!## '#$$&"#$$& %1

<8' '#$%%%%#!$$&%1 '! !#,9789$$!'$

$!0 !$*$%!0-#2#- !!# #%#%'%$%%'+#%%) - 1';;:! !#,$%%9789'#:9=5>;A6-%!#!<9A'#!$%%

$!1

%9789%9:@%# % $%%%' # !%8>=%#

97881 $$!'$ %$!$%%$!#%9789"*'$%8?8

%#!%8::97881 #%- '! !#, %$$!!#*%$

977@$)$$%!###&'! !#, !$% 1'9:@! !#,%

% %$9789'#8<@%#"*'$%!%88?97881#%%'

$!"*'$$2"!$%'#$)"%!%$ $! $# &$1 '$$

"$ % '%#!%#!#%%& !$%$#%1 # %2

"*'$% $! # %$#"#$ %###!# -' '$ %$'# $%!#

# $ $1'9:@$%9789'#8<85=:A6$%%%$!587>978860 :?'#$%%% #$%#!#5'!#'$$# 0#! !#

#"$!#61';@$%%%&% %'#8;$%%%)$ 5!'$# 60

%!##% !#'1" 0'#!18;95<@A6'% % 9789!""#%$%%%' %"#% #0<@'$%"#% #!!#:?'#

#$! %"#% # 3& %1 #!#9:@ !$%$#%9789'#:8

*#58?2=860&!# #%#$$%%!*#1 %) '$$! !$%$#$

! !#,# %'"!$%'5:?'9:@%#978961

'8;@%#!$$&%$%% '#>;5<7A6$%%%&% %1 !

"" #!#%$%%)""$%$%%$% &% %!# ;9%#

97891'>; $%%%!#'#8@$%%%$!5!%:8978860$$#!$-!

'1#! !%' #1-'#% '#$"#%"*:7!& #!'#

%1'<;' !""#;75>;A6%$%%%!#0'!#'8;$!0

# !%##!$-18;' $%%%&% %'#!'$$%%%

&#!"1' !""#8875>;A6%$%%%' %"#% #5'!#' '-"'$$&% $%#0&% %60 $;@A'' !""#%32

$!## $%"#% #$!$%%1 #!#8;@%#!$$&%

$%% '#:7*#58<2=?*#6!!#<8' 9;*#58=4<8*#61

(15)

!#(! $ "!!#3772/

!!)!!%! !!)%.%&% !

"051. & !## % &!)%!#&

". ! !! # %#! $ ,

!! !! & !! !)#, ' !)%

,!#.

!!!#(!! " ! !!&!#!#&.

!!# ! !!!#"! , !)) !/ , #) ! ! !!

"!!!#!&"!# ! % ! "!)!

!#(%& !"!.!! ' !#! !#& ! % !&) !.# ! !

!#'!!!!#,&## !#!&

).%! !!"' ! !0"!

(1"!!#!! !!' " ! 4235. !" &! 622 !!

!" "'! !#(.

$ #&&%!$"#$

-, !!"!!!

Homoseksuelle menn

Heteroseksuelle menn Heteroseksuelle kvinner Antall

(16)

#0881!%##

#-.+!!$!#'%$'!

##*%* %#-!+,

$. +$!!

$ !'!*#!*

$! $

$#,!+

1/010/8-1*10/////.!%* %

#-02/1/00.+!1/01!85-779.

02 +'##,

"-.1/00*#

1/01*$'#!$+

$1/01$!!$- 2.+0/8$0/5!+539!

1/01+

*!!

$$ +!85, 1/01!5/-531/00.*01!

-!!.11! * +

! +!851/01!60-639.' + !32$-06,58.+1/0153 -569.!#!*

05!05! +

$#!#!!

-34!851/01.+

!02 1/01-101/00.*!0/

!*!!!!+!02 * -!!.* +!20$

-08,51.!22$-20,3/.+

!#" !088/, '#'#-2.+#$#

+$!!&$'#!$

+!#!"*

$'! *%'#*

!+#

# +

(17)

" ##"! !

(18)

" !" )

"(

$ !

""(/--2$&$"&

$ * $ (

/-.//.145 !+10.

.---,("1(26"("/--4

!"4&26($

!+.2).5",(

/-./ 3-6 (/2"$346 +/-)/1"136.2).5"//6,(

/2"$ 336 ($

& 0-" +236,(

$ #""(

! #(

$!/--4&" # .2).5"/-..

#$/-)/1"+12,(

! (/-./ .2).5"

"/--2($ # (

&! %##'"%#$%

' &

(19)

" !"! !

& %

%

!!!

'!!

'.,-.# .253./'

"!!#"

'#! .,-.!

4%,6*.-045).253./+'!!'

#!%"

.,-.!!'

!

##(

!'.,-.#5.6

##!%-3-5 '

3.6#2%16 '# -,%56' # -1(-5!*-/6 -1%16+.,(.0!*5%36-2%06+' .1(.5!!--6'#

# '

(20)

/.$$ "

"$ % * "&

"*

(%"*

$ " % (&"*&$

"

"$$ *

&"*

"$$

$*

&$ &" *

& &

$&

* &"(

"*"

"(02$ +

"( **

"%,

"- % 0./1*$""/..!03(""

0..!/3(#"/*#"&$

*$ "" %

$ #"* #"/

2..!13*

"!

)(

0 200 400 600

1986 1989 1992 1995 1998 2001 2004 2007 2010 Antall tilfeller per 100 000

(21)

!%! .642)/-./1-

!+-(5.---,) !!

(!! )!!

3$(!!!&

)/-./ (!

/-./*%)

#)

$ %*

)! $&

! !)

"!% ) &.664*65/--1)*

&.662*66 .03- )

# %$

!!! !

#%#+1,)/-./ &.03#

!!*)

#!"

Serologiske og genteknologiske analyser Anti-HAV IgM, ELFA

Anti-HAV (IgM og IgG), ELFA

HAV RNA, RT-PCR (kvalitativ) (virus i blod) HAV-genotype, sekvensering

/--4/-.. !*!+!"",

!.-05104320/$) *!$$

$.2//--433!/-..)

(22)

!!!#&!!# !!2:86-2::3!!

!"!!! !!!-

3123!!!57!#"!!!!!/1+:!2111110-#

#96; !!! "!+ !! "!-#22! "!

"! !!#!#%!!+"! . !!#53%- ! !! !!! "! !!#

7!!3123-#29! "! !!#22#

$#+ !!#51%-! !!'

# !!## -! "! !!#

!!!-$ ! !!3123#26% !#

!!%!"!-

# $# ! " ! !3123##

!!!-

( %##) %#$%

%##) %##* %##+ %##, %#$# %#$$ %#$%

+( *% )( && ) %, +

') &- &, %- %, && &-

- ) * ( % ( (

%( + ' ) & & *

%

& % & %

!! & %

%' %* %$ ) % , %

$', $%# $#& (( %* () ')

,+ !!"!!!

3123!!!771 ! !!# !!!-:7;#

!# # !!! !!!(#!- !( !"/:4 0#(!-(!#

!+ !+ +!-3123!!!!!#

!!! !!(!# !#-! %!!

""# !!! -

) %##& %#$%

%##& %##' %##( %##) %##* %##+ %##, %#$# %#$$ %#$%

,' *' (, )$ (( )- '( )( '( &(

+%) *%& )$& (+, ()' )-' +,) *+, **- *'(

) %& * - ) * , & &

* &% %( - %% %* ) ( % +#, *#+ (*# (') ($' )*' +&% *&) *#) ))#

,+ !!"!!!

(23)

!!!# ! "! !!"!2874+! #"!!

!!!!2885/60-2885.3117#!! !!"!"

! ! "-!!2834!#"!!

!!!"-!% ! !!#"!!!!! !

& ! ! &!#!#&-#(#!!!# !!&!

(%! " $"#/!50-

!21.31!#"!!!!!!! " !!!-

!## ! &# !! ! "!-

# ! "!!!!!!!"! -

!!# ! !!"!#!!!&!

!&-

3112.3123!!!!31!# !!!

.!. !!-" !!#(#% !!(

&(% !#!!!+#!!! !!("

# !#! ! '-! .

"#+#!& !1!3!#!!! .

!! ! -!!! !!# ! !!!!.

! (%! #'! !-

& #"""""#'&%!$"#$

,+ !!"!!!

0 2 4 6 8 10 12

1975 1980 1985 1990 1995 2000 2005 2010 Antall tilfeller per 100 000

(24)

!!$ "!!&!%

# !!!#!!#"!!#

$& $ .!5/+

2012!"!'!4765$ !!!,#" . /, )

###!#$ "!#" #!!+!!"!'!215

$ #! ! # , ##+

- ! !.1-2012/!3 "'# !

$!!!! , .3/+2012!" ! !"!765!,

"#! %# # !, .!6/+

* !

Serologiske og genteknologiske analyser HBsAg, ELISA

Anti-HBs (Total), ELFA HBc-IgM (IgM), ELFA Anti-HBc (total), ELISA HBeAg, ELFA

anti-HBe, ELFA

HBV kvantitativ/kvalitativ (qPCR)

HBV-genotyping/small S-gen (sekvensering) HBV-resistens (sekvensering)

HBV-precore mutanter (sekvensering)

+ #"$

(&&)"(&'(

År HBsAg Anti-HBc

2005 448 76

2006 452 211

2007 536 311

2008 655 535

2009 675 605

2010 770 345

2011 586 345

2012 552 435

*##) !!"!!!

! !##%# !!%# .! /#

!!! )!$#!!! , ! !!#

!+

,!$" !" +!$") ! " % ! !"!+!$ ', ! )!$!$!!!+ ,!$!$ $ '

(25)

!!&" ) "% !!&

"$ #!,"- * +"%!

!!! "" !!$"!%! '"%*0./0"#"' "/4.

%! +"%* !"$"%+ "$"!"$ &

"!# !'!"&,5-*"%#"' /.6)!'$ "%) !"&$!" *

Kilde: Avdeling for virologi, Folkehelseinstituttet

" 3""$ " """""

" ,2-*$#)$ "$ " ! "

"&$ )!"$ "#$ " # +*" !$ !"$ "!" &

)" !" !" "!" '$ !!!"$ #!$

$"" $$ #!# "*2..!" &

""""$ " ,2-*' !","$

"$ -%""!' #" 0./0*456$3"!

" +*

!!"!""$ " """+$ #!# !'!$

$ #! ## )$ $&!!&# !'!$

+"%*!!"!$ $&#"' !!" !# !'!

+"%!$#" '$"!"*"

#" !!"!"# !'" +"%0./0,2-*#1"

!!"!"!"" !) #/"$ !!"!&$!"*

26

22 22 23 24

22

20 21 20

19 19

21 20

26

16 26

29 30

22

32

8 8 7 9 9

0 5 10 15 20 25 30 35

2008 2009 2010 2011 2012 A B C D E

Antall

(26)

!##087;1% !)%!"""""##$###!&### #/

"#,%!%% !#$#)!%!$"%##!.""##$###!#

"#!#!#!"$#)!!%!$"!#!"!$#""#"!

"#"%$$#"!/#& ,"#%'!#!!"$#)!!

%!$"%##!.

!!!##!#!""#" !#&### #/

061."#!")!)!"##%!#%!""

#!#!"""!#!""#"$#%.##!%!"/

"#"%!%'"#!!""#"!$## '%"#4234 061. #! "# !)%!"""!&"!)!

%!%'"#!%!$"!""#"$"!.#!"!!"&"##"

%!%'.

###/%"$#%!"!""##$####!$!%"""/

!!#!!%!!"!!/%"!'

'!$ !%!%"""%#!&##!'!" #!"!#.#

"" ###/%"#&!"%""#!"%""'!"/

"##$###!!!"""#!.

!4229! ###/%"%!%""" !!#!!%

!! !"$#!%"!'.#!"!

!###!#. &"!!!")!!#

"#%"""!"#!01,#!!!%"'%$!!

###/%"""!!$ .##"#!%"!#

52;%!)#422:,4232,42334234!'##"#(" ###/%"

) #%"##)!"#%'!.

- !

&$$-!&$%&

&$$- &$%$ &$%% &$%&

" *+* )-) )-( )..

"# '-(& '*&( '*,, ',**

" ..* ,+. ++* +')

" !

! / (- )( '-/

" (,() '//& '/+' ((--

" & & & &

" ',+* '*&, '-)) '+*.

## -& ',+ '&+ '' +'(( ),)* *&%' *)*$

* stoffmisbrukere, menn som har sex med menn og prostituerte

** For 1-2 % av reseptene var indikasjon ikke nedskrevet (telefonresepter).

-%!%",""##$###

(27)

)$""$$"")*"%#*$"#$!

*$#)$"")('("

$"#$$%,

$"") (&((+

$""*)$(#+$"#$

#*&'$"")+'$$"#$

(28)

!!!#&!!# !! 088/*088/+0880 !+! '#*0881+1//6#"

"!!!!! !*1//7%# #!+, !*

1/01!! !0402$!#!!!-18)8!0/////.*

!"% ## #"!!!*709#!!! !!!

)#259#!#!!! !!#!! #749 !!!

# '$!"*#!!! !!!"!' #

!-0391/01.# ! !!#!!!* !!

!!1/01#28%)*! %!*

!!!+ !" # '!#

!!!! !!!!%% " "*#!%

!04//+1///!#!!!* % !!!

!"!'!# " ' ##!!

0882* " !!) * ##% +

!!!!!1//7%# #!+,+

! !*#"!!!!! !*!

! !#$ !!!!!!# !!

% *!# # #!!!

#" !) !!'*!"# !!*/)49

# ! !!!!!*!!$!! # 1////+2//// #&! !!!!!!+#" !*

!!$ "!!&!%

# !!!#!!#"!!#

$& $ *1/01!"!'!0525$

* #!"!'!17/$ #! ,+

! #!#'## * , ! ! -1,1/01.!#!*!" ! !"!306

!+"#! %# #!+!

!*

$#!"

!

Serologiske og genteknologiske analyser Anti-HCV (ELISA)

Anti-HCV, RIBA HCV RNA (RT-PCR)

HCV RNA-kvantitering ( bDNA) HCV- Genotype (InnoLiPA)

(29)

* #" #"'" $'#

" )

" 3-- */-./"

)1-5 " +1,)

/-./ ! % //4#* #+4,) "

!%" ! * #0+125,.+0.5,) #. #.#

" !* #.)

(""' !

! " * #0+125,)

""!% ! # 0! %)" " '$ "!) * #0#$ !%# "

#0" * !"

$$

!!)

0 20 40 60 80 100 120 140

1a 1b 2 3 4,5,6 Ikke typbar 2008 2009 2010 2011 2012

Antall

(30)

&!!(

.,,.'-44-(.,,.-/!&

'.0!&

* --&3&) 1+'

$"' .,-.23$! $(! ! (

"'#!0 ('!"!

!* -&-& -+&-"

( '#!-,!#' ( $--1"&!!3!

$#)'

Serologiske analyser Anti-HEV (IgG), ELISA Anti-HEV (IgG), ELISA Anti-HEV (IgM), ELISA HDV-Antigen, ELISA anti-HDV (IgG), ELISA

(31)

"$!")"!##$#"!"#"!$!"!$#)!#'!"

8667!#"!"##"$+# !"##1

!""!""##$###-$#8678###!# ! 8=-6=-7826>-6>-78###%""# ###$!")"!

###+"#%-!#!$!")"!'!"$#)!#%

+%!%!-

8678##"77; !"!"$!")"#"!

"#"!$!"-"$##!!%#79!%"#!#3<;4

!3:64-##!!%!#!#!'!-##"&"""&%"#

/$0!" !)&#$#&###!##)!$!")"!###!#+

#! '&/$%#0""$!")"!$#)!#-#!&#%!##

%!(!!"##" !)&#!$-

""!$!")"!!!!#) #%'!+"#

!!$##!"!$#!!#%!'!!!!#!$#

"!#-

#!8678" !#!!#!'!-!"#%'##1!"

."!!#)&+%!%-# '%"#$#%.#

$%!". "#%$##1!"."-

!"

" !"

/ 1*) / 1'#

)# '#)* )* %%&&

0 $ $*& # #&*

0 &% %'*) '& $*'#

0 '& %%($ &) +%%

0 &$ %%&% %% +&*

0 )% '**) )+ %*'#

00 *# &&*# )* $+%*

0 # #%, + $$&

)% '**) *# %+'#

$ # #*( & $'#

5%"!#3#."""#.!)!4#"!#.#%

3"###4+#%"%"!#'!$ !%"

55#. "#%1! "#%!.

,%!%!+""##$###

(32)

)% !#$$

*()(%*()*%

*% &)&*()+%%

+% &*&*()+%%

,% *())')*%

"%*()+.

(33)

www.fhi.no

Utgitt av Nasjonalt folkehelseinstitutt Desember 2013

Postboks 4404 Nydalen NO-0403 Oslo

Telefon: 21 07 70 00

Rapporten kan lastes ned gratis fra Folkehelseinstituttets nettsider www.fhi.no

Blod- og seksuelt-

overførbare sykdommer

Årsrapport 2012

for sykdomsprogrammet

Hans Blystad Hilde Kløvstad Venelina Kostova Øivind Nilsen Synne Sandbu

Kathrine Stene-Johansen Martin Steinbakk

Per Kristian Svendsen Inger Sofie Samdal Vik

2013

Referanser

RELATERTE DOKUMENTER

Askelund, Anders Bergh, Øivind Bjørgaas, Per Samuel Boonstra, Eelco Borstad, Vigdis Bruer, Åse Liborg Chapman, Martin David Eichste er, Birgit Leikanger Flaaen, Hermod..

Dette er en meget komplisert prosess som ikke sjelden kan gå galt og forårsake mange sykdommer hos mennesket, sier professor Steinar Johansen ved Institutt for medisinsk

Carsten Strobel, Olav Aga, Peter Bekkhus-Wetterberg, Guro Bjørkløf, Martin Brierley, Martin Bystad, Knut Engedal, Per Kristian Haugen, Hans Johansen, Katinka Odner &amp; Tor

I 2018 mottok Folkehelseinstituttet 52 varsler til Vesuv om mistenkte eller verifiserte næringsmiddelbårne utbrudd utenfor helseinstitusjoner (Tabell 6).. Antallet har gått noe

I 2019 mottok Folkehelseinstituttet 46 varsler til Vesuv om mistenkte eller verifiserte næringsmiddelbårne utbrudd utenfor helseinstitusjoner (Tabell 6).. Antallet varslede

Avdeling  for  virologi  ved  Folkehelseinstituttet  er  nasjonalt  referanselaboratorium  for   hepatitt  virus  og  kan  gjennom  supplerende  og

Nære venner av Schubert på denne tiden var den begavede, men rastløse Franz von Schober (1792 – 1882), som senere bl.a.. var Listz&#34; sekretær, og Anselm Hü

november 2012: Professor Hans Christian Bugge (medlem av Brundtlandkommisjonen), foredragsholderen professor Iris Borowy, Selskabets leder professsor Øivind Larsen.. (Foto: